MassBio and Google are partnering to offer a two-day customized training program (September 16 & 17 | In-person: Google, Cambridge) about AI for drug discovery.
Register now: With limited seats available, we encourage you to register now (Members: $150 | Non-members: $200) to ensure your place in this indispensable training opportunity.
- Familiarity with basic Cloud concepts and navigation is the only prerequisite.
What you’ll learn on Day 1: This intermediate-level training delves deeper into utilizing Google Cloud for advanced life sciences workflows.
- Participants will explore key Google Cloud services for data management, high-performance computing, and AI/ML to accelerate research and development.
Advanced training on Day 2: This advanced training focuses on leveraging Google Cloud’s cutting-edge AI/ML tools and scalable infrastructure for tackling complex drug discovery challenges.
- Participants will delve into advanced techniques for deep learning, generative AI, and specialized applications in genomics, proteomics, and clinical trial optimization.
- The curriculum emphasizes building and deploying production-ready AI/ML pipelines on Google Cloud, utilizing services like Vertex AI, BigQuery ML, and specialized accelerators.
Your takeaways: All participants can take a test to receive a Google Cloud Generative AI Leader certificate after Day 2.
- Learn more about the skills you’ll gain and tasks you’ll be able to execute following each day of training.
Hands-on labs: Lab sessions on Day 1 will provide practical experience with relevant Google Cloud tools and services. Advanced labs on Day 2 may utilize real-world pharmaceutical datasets (anonymized or synthetic) to deliver practical experience in implementing advanced solutions.
Networking reception: At the conclusion of day one, participants can mingle with each other and the teams from MassBio & Google Cloud at an on-site networking reception.
What we’re saying: “AI is changing drug development at a breakneck pace, and the biotech workforce needs to be upskilled to take advantage of the latest tools,” said MassBio CEO and President Kendalle Burlin O’Connell. “MassBio and Google are teaming up on this training program that has been tailormade for biotech employees as another way to support the companies that are working to deliver for patients.”